|
|
Article: Endocare Expands Agreement to Distribute 15-Minute PSA Test to Urologists; Expands Existing OEM Agreement With Qualigen Physician Office Lab System.
- Article from:
- PR Newswire
- Article date:
- October 8, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif., Oct. 8 /PRNewswire/ --
Endocare, Inc. (Nasdaq: ENDO), a developer of innovative temperature-based treatments for prostate cancer and prostate obstruction, today announced that it entered into a new expanded distribution agreement with privately held Carlsbad, CA-based Qualigen, Inc. Under the new agreement, the Endocare sales force will now sell Qualigen's FDA-cleared, 15-minute total prostate specific antigen (Total PSA) test as a stand-alone product, non-exclusively directly to urology practices. The test, which provides rapid, fully-automated, laboratory quality PSA test results in physician office laboratories, eliminates patient anxiety that ...